- Email: [email protected]
Author index (vol. 60)
Atherosclerosis, 60 (1986) 295-297 Elsevier Scientific Publishers Ireland,
295 Ltd.
Author Index (Vol. 60)
Aigner-Held. R., see Malinow, M.R.. 15 Algoed, L.. see Delanghe, J., 215 Amy, R.M., see Russell. J.C., 119 Araki, G., see Homma, Y.. 23 Bailey, K.R.. see Hoeg. J.M., 209 Balasubramaniam, S., L.A. Simons and S. Chang (Effects of Ro 16-0521 on cholesterol metabolism in the rat), 263 Ball, H.Y., J.P. Bindman, K.L.H. Carpenter and M.J. Michinson (Oxidized low density lipoprotein induces ceroid accumulation by murine peritoneal macrophages in vitro), 173 Bargel. R., see Beitz. J., 95 Bargeron. C.B., see Friedman, M.H., 167 Bates, M.V., see Deutscher, S.. 221 Beatty, C.H.. C.F. Howard, Jr. and V. Caruso (Effects of ADP and epinephrine on macaque and human platelets - Implications for studies on human atherosclerosis), 111 Behall, K.M., see McIvor, M.E., 7 Beilin, L.J.. see Masarei. J.R.L., 79 Beitz, A., see Beitz, J., 95 Beitz, J.. H.-U. Block, A. Beitz, G. Miller, L. Winkler, R. Barge1 and H.-J. Mest (Endogenous lipoproteins modify the thromboxane formation capacity of platelets), 95 Berenson, G.S., see Radhakrishnamurthy, B., 141 Beynen. A.C., R. Van der Meer and C.E. West (Mechanism of casein-induced hypercholesterolemia: Primary and secondary features) (Letter to the Editors), 291 Bhandaru, R.R., see Radhakrishnamurthy. B., 141 Bindman. J.P., see Ball. H.Y., 173 Block. H.-U.. see Beitz, J., 95 Brewer. Jr., H.B., see Hoeg, J.M.. 209 Caines. M.J., see Deutscher, S., 221 Carpenter, K.L.H., see Ball, H.Y., 173 Caruso, A.. see Musumeci, V.. 231 Caruso. D., see Eynard. A.R.. 61 Caruso, V., see Beatty, C.H., 111 Chang, S., see Balasubramaniam. S., 263 Cighetti, G.. M. Del Puppo. R. Paroni, G. Galli and M. Galli Kienle (Effects of pantethine on cholesterol synthesis from mevalonate in isolated rat hepatocytes). 67 Connor, W.E., see Malinow, M.R., 15 Cummings, C.C.. see Mclvor, M.E.. 7 0021-9150/86/$03.50
0 1986 Elsevier Scientific
Dahlen. G., see Hamsten, A., 199 Davis, P.F. and W.E. Stehbens (The biochemical composition of haemodynamically-stressed vascular tissue, Part 2 (The concentrations of protein and connective tissue components in the salt extracts of experimental arteriovenous fistulae)), 55 De Buyzere, M.. see Delanghe. J.. 215 De Faire, U., see Hamsten, A.. 199 Delanghe. J., J. De Scheerder. M. De Buyzere, L. Algoed and J. Robrecht (Macro CK type as a marker for autoimmunity in coronary heart disease), 215 De Leeuw. I.H., see Van Gaal. L.F.. 287 Del Puppo. M., see Cighetti. G.. 67 De Scheerder, J., see Delanghe, J., 215 Deters, O.J., see Friedman, M.H.. 161 Deutscher. S.. M.V. Bates, M.J. Caines. R.E. LaPorte. A. Puntereri and F.H. Taylor (Determinants of lipid and lipoprotein level in elderly men). 221 Dumont. E.. see Renaud, S.. 37 Duner, E.. see Lapolla. A., 151 Eynard. A.R., E. Fremoli, D. Caruso. C.R. Sirtori and G. Galli (Platelet of 12-hydroxyeicosatetraenoic thromboxane B, is increased in hypercholesterolemic SubJects), 61
F. Magni. formation acid and type IIA
French. S.W.. see Nanji, A.A., 197 Friedman, M.H., O.J. Deters. C.B. Bargeron, G.M. Hutchins and F.F. Mark (Sheardependent thicknening of the human arterial intima), 161 Fosslien, E., see Stastny, J., 131 Galli. G.. see Cighetti. G.. 67 Galli. G., see Eynard, A.R.. 61 Galh Kienle, M., see Cighetti, G., 67 Godsey. F., see Renaud, S.. 37 Goto, Y.. see Homma. Y.. 23 Grab, B.. see James, R.W., 49 Hamsten, A., L. Iselius, G. DahlCn and U. de Faire (Genetic and cultural inheritance of serum lipids. low and high density hpoprotein cholesterol and serum apolipoproteins A-I, A-II and B). 199 Hill, T.. see Kohlmeier, M.. 29 Publishers
Ireland,
Ltd
296
Hoeg, J.M., M.B. Maher, K.R. Bailey and H.B. Brewer. Jr. (The effects of mevinolin and neomycin alone and in combination on plasma lipid and lipoprotein concentrations in type II hyperlipoproteinemia), 209 Homma, Y., Y. Mikami, H. Tamachi. N. Nakaya, H. Nakamura, G. Araki and Y. Goto (Comparison of selectivity of LDL removal by double filtration and dextran-sulfate cellulose column plasmapheresis), 23 Howard, Jr., C.F., see Beatty, C.H., 111 Hutchins, G.M., see Friedman, M.H., 161 Isabelle, L.M., see Malinow, M.R.. 15 Iselius, L., see Hamsten, A., 199 Ishibashi, S., see Murase, T., 1 James, R.W., B. Martin, D. Pometta, B. Grab and A. Suenram (Apoprotein D in a healthy, male population and in male myocardial infarction patients and their male, first-degree relatives), 49 Jiao. S.. K. Kameda, Y. Matsuzawa, M. Kubo, K. Nonaka and S. Tarui (Influence of endogenous hyperinsulinism on high density lipoprotein, level in type 2 (non-insulin-dependent ) diabetes mellitus and impaired glucose tolerance), 279 Kameda, K., see Jiao, S., 279 Khashinov, Kh.A., see Orekhov, A.N., 101 Kohlmeier, M., T. Hill, P. Remer and G. Schlierf (Influence of bezafibrate on plasma lipoproteins, biliary lipids and fecal sterols in healthy men), 29 Konarska, R., M. Shaikh, A. La Ville and P. Turner (Immunoglobulins containing circulating immune complexes in hypercholesterolaemic patients) (Letter to the Editors), 89 Kotake, C., see Murata, K., 251 Kritchevsky, D., see Sparks, J.D., 183 Kubo, M., see Jiao, S., 279 Kudryashov, S.A., see Orekhov, A.N., 101 Lapolla, A., P. Tessari, E. Duner, R. Trevisan, V. Zordan, R. Nosadini and A. Tiengo (Hormonal and metabolic profiles in patients with alcohol-induced, mixed hypertriglyceridemia before and after abstinence from ethanol and before and after a lipid-lowering diet), 151 LaPorte, R.E., see Deutscher, S., 221 La Ville, A., see Konarska, R., 89 Leo, T.A., see McIvor, M.E., 7 Lin, D., see Malinow, M.E., 15 Lynch, W.J., see Masarei, J.R.L., 79 McIvor, M.E., C.C. Cummings, M.A. Van Duyn, T.A. Leo, S. Margolis, K.M. Behall, J.E.
Michnowsky and A.I. Mendeloff (Long-term effects of guar gum on blood lipids), 7 McLaughlin. P., see Malinow, M.R., 15 Magni, F., see Eynard, A.R., 61 Maher, M.B., see Hoeg, J.M., 209 Malinow, M.R., P. McLaughlin, R. Aigner-Held, B. Upson, L.M. Isabelle, W.E. Connor and D. Lin (Absorption of cholesterol and /3sitosterol from cigarette smoke in Macacn mulatta), 15 Margolis, S., see McIvor. M.E., 7 Mark, F.F., see Friedman, M.H.. 161 Martin, B.. see James, R.W., 49 Martin, J.C., see Miller, G.J., 269 Martin, J.L., see Renaud, S., 37 Masarei, J.R.L., I.B. Puddey, I.L. Rouse, W.J. Lynch, R. Vandongen and L.J. Beilin (Effects of alcohol consumption on serum lipoprotein-lipid and apolipoprotein concentrations - Results from an intervention study in healthy subjects), 79 Mastacchi, R., see Radhakrishnamurthy, B., 141 Matsuzawa, Y., see Jiao, S., 279 Meade, T.W., see Miller, G.J., 269 Mendeloff, A.I.. see McIvor, M.E., 7 Mendy, F.. see Renaud, S., 37 Mest, H.-J., see Beitz, J., 95 Michnowsky, J.E., see McIvor, M.E., 7 Mikami, Y.. see Homma, Y., 23 Miller, G.J., J.C. Martin, J. Webster, H. Wilkes, N.E. Miller, W.H. Wilkinson and T.W. Meade (Association between dietary fat intake and plasma factor VII coagulant activity - A predictor of cardiovascular mortality), 269 Miller, N.E., see Miller, G.J., 269 Mitchinson. M.J., see Ball, H.Y., 173 Morazain, R., see Renaud, S., 37 Mori, N., see Murase, T., 1 Mori, W., see Murase, T.. 1 Motoyama. T., see Murata K., 251 Muller, G., see Beitz, J., 95 Murase, T., T. Oka, N. Yamada, N. Mori, S. Ishibashi, F. Takaku and W. Mori (Immunohistochemical localization of apolipoprotein E in atherosclerotic lesions of the aorta and coronary arteries), 1 Murata, K., T. Motoyama and C. Kotake (Collagen types in various layers of the human aorta and their changes with the atherosclerotic process), 251 Musumeci, V., S. Rosa, A. Caruso, C. Zuppi, B. Zappacosta and F. Tutinelli (Abnormal diurnal changes in in-vivo platelet activation in patients with atherosclerotic diseases), 231
Nakamura. H., see Homma, Y., 23 Nakaya, N., see Homma, Y., 23 Nanji, A.A. and S.W. French (Alcoholic
bever-
291
ages and coronary heart disease) the Editors), 197 Nonaka. K., see Jiao, S., 279 Nosadini, R.. see Lapolla, A.. 151
(Letter
to
Oka. T., see Murase. T., 1 Orekhov. A.N., V.V. Tertov. S.A. Kudryashov, Kh.A. Khashimov and V.N. Smirnov (Primary culture of human aortic intima cells as a model for testing anti-atherosclerotic drugs Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipidlowering agents), 101 Paroni, R.. see Cighetti, G., 67 Pometta, D.. see James, R.W., 49 Puddey, LB., see Masarei, J.R.L., 79 Puntereri, A.. see Deutscher, S., 221 Radhakrishnamurthy. B., C. Sharma. R.R. Bhandaru, G.S. Berenson, L. Stanzani and R. Mastacchi (Studies of chemical and biological properties of a fraction of sulodexide, a heparin-like glycosaminoglycan). 141 Remer, P., see Kohlmeier, M., 29 Renaud, S.. R. Morazain, F. Godsey, E. Dumont, C. Thevenon, J.L. Martin and F. Mendy (Nutrients, platelet function and composition in nine groups of French and British farmers). 37 Robertson. Jr., A.L.. see Stastny, J.. 131 Robrecht. J., see Delanghe, J., 215 Rosa. S., see Musumeci, V.. 231 Rouse, I.L.. see Masarei, J.R.L.. 79 Russell, J.C. and R.M. Amy (Early atherosclerotic lesions in a susceptible rat model - The LA/N-corpulent rat). 119 Schlierf. G., see Kohlmeier. M., 29 Shaikh, M., see Konarska. R., 89 Sharma. C., see Radhakrishnamurthy. B., 141 Simons, L.A., see Balasubramaniam, S., 263 Sirtori, C.R., see Eynard, A.R., 61 Smirnov, V.N., see Orekhov, A.N., 101 Sparks, C.E., see Sparks, J.D., 183 Sparks, J.D., C.E. Sparks and D. Kritchevsky
(Hypercholesterolemia and aortic glycosaminoglycans of rabbits fed semi-purified diets containing sucrose and lactose), 183 Stanzani, L., see Radhakrishnamurthy, B., 141 Stastny, J.. E. Fosslien and A.L. Robertson. Jr. (Human aortic intima protein composition during initial stages of atherogenesis). 131 Stehbens, Suenram,
W.E., see Davis, P.F.. 55 A., see James. R.W., 49
Takaku, F., see Murase, T.. 1 Tamachi, H., see Homma. Y.. 23 Tarui, S.. see Jiao, S., 279 Taylor, F.H.. see Deutscher, S.. 221 Tertov, V.V., see Orekhov, A.N., 101 Tessari, P., see Lapolla, A., 151 Thevenon, C., see Renaud, S., 37 Tiengo, A., see Lapolla, A.. 151 Tremoli, E.. see Eynard, A.R., 61 Trevisan, R.. see Lapolla, A., 151 Turner, P.. see Konarska, R.. 89 Tutinelli, F., see Musumeci, V.. 231 Upson.
B., see Malinow,
M.R., 15
Van der Meer, R.. see Beynen, A.C.. 291 Vandongen. R., see Masarei, J.R.L., 79 Van Duyn, M.A., see M&or, M.E., 7 Van Gaal, L.F. and I.H. De Leeuw (Effects of smoking on lipid parameters during therapeutic weight loss) (Preliminary Note), 287 Velican, C. and D. Velican (Atherosclerotic involvement of coronary branch vessels), 237 Velican, D., see Velican. C., 237 Webster, J., see Miller, G.J.. 269 West. C.E.. see Beynen. A.C., 291 Wilkes, H., see Miller, G.J., 269 Wilkinson, W.H., see Miller, G.J., 269 Winkler, L., see Beitz, J., 95 Yamada.
N., see Murase,
T., 1
Zappacosta, B.. see Musumeci, V.. 231 Zordan, V., see Lapolla. A., 151 Zuppi, C., see Musumeci. V., 231
295 Ltd.
Author Index (Vol. 60)
Aigner-Held. R., see Malinow, M.R.. 15 Algoed, L.. see Delanghe, J., 215 Amy, R.M., see Russell. J.C., 119 Araki, G., see Homma, Y.. 23 Bailey, K.R.. see Hoeg. J.M., 209 Balasubramaniam, S., L.A. Simons and S. Chang (Effects of Ro 16-0521 on cholesterol metabolism in the rat), 263 Ball, H.Y., J.P. Bindman, K.L.H. Carpenter and M.J. Michinson (Oxidized low density lipoprotein induces ceroid accumulation by murine peritoneal macrophages in vitro), 173 Bargel. R., see Beitz. J., 95 Bargeron. C.B., see Friedman, M.H., 167 Bates, M.V., see Deutscher, S.. 221 Beatty, C.H.. C.F. Howard, Jr. and V. Caruso (Effects of ADP and epinephrine on macaque and human platelets - Implications for studies on human atherosclerosis), 111 Behall, K.M., see McIvor, M.E., 7 Beilin, L.J.. see Masarei. J.R.L., 79 Beitz, A., see Beitz, J., 95 Beitz, J.. H.-U. Block, A. Beitz, G. Miller, L. Winkler, R. Barge1 and H.-J. Mest (Endogenous lipoproteins modify the thromboxane formation capacity of platelets), 95 Berenson, G.S., see Radhakrishnamurthy, B., 141 Beynen. A.C., R. Van der Meer and C.E. West (Mechanism of casein-induced hypercholesterolemia: Primary and secondary features) (Letter to the Editors), 291 Bhandaru, R.R., see Radhakrishnamurthy. B., 141 Bindman. J.P., see Ball. H.Y., 173 Block. H.-U.. see Beitz, J., 95 Brewer. Jr., H.B., see Hoeg, J.M.. 209 Caines. M.J., see Deutscher, S., 221 Carpenter, K.L.H., see Ball, H.Y., 173 Caruso, A.. see Musumeci, V.. 231 Caruso. D., see Eynard. A.R.. 61 Caruso, V., see Beatty, C.H., 111 Chang, S., see Balasubramaniam. S., 263 Cighetti, G.. M. Del Puppo. R. Paroni, G. Galli and M. Galli Kienle (Effects of pantethine on cholesterol synthesis from mevalonate in isolated rat hepatocytes). 67 Connor, W.E., see Malinow, M.R., 15 Cummings, C.C.. see Mclvor, M.E.. 7 0021-9150/86/$03.50
0 1986 Elsevier Scientific
Dahlen. G., see Hamsten, A., 199 Davis, P.F. and W.E. Stehbens (The biochemical composition of haemodynamically-stressed vascular tissue, Part 2 (The concentrations of protein and connective tissue components in the salt extracts of experimental arteriovenous fistulae)), 55 De Buyzere, M.. see Delanghe. J.. 215 De Faire, U., see Hamsten, A.. 199 Delanghe. J., J. De Scheerder. M. De Buyzere, L. Algoed and J. Robrecht (Macro CK type as a marker for autoimmunity in coronary heart disease), 215 De Leeuw. I.H., see Van Gaal. L.F.. 287 Del Puppo. M., see Cighetti. G.. 67 De Scheerder, J., see Delanghe, J., 215 Deters, O.J., see Friedman, M.H.. 161 Deutscher. S.. M.V. Bates, M.J. Caines. R.E. LaPorte. A. Puntereri and F.H. Taylor (Determinants of lipid and lipoprotein level in elderly men). 221 Dumont. E.. see Renaud, S.. 37 Duner, E.. see Lapolla. A., 151 Eynard. A.R., E. Fremoli, D. Caruso. C.R. Sirtori and G. Galli (Platelet of 12-hydroxyeicosatetraenoic thromboxane B, is increased in hypercholesterolemic SubJects), 61
F. Magni. formation acid and type IIA
French. S.W.. see Nanji, A.A., 197 Friedman, M.H., O.J. Deters. C.B. Bargeron, G.M. Hutchins and F.F. Mark (Sheardependent thicknening of the human arterial intima), 161 Fosslien, E., see Stastny, J., 131 Galli. G.. see Cighetti. G.. 67 Galli. G., see Eynard, A.R.. 61 Galh Kienle, M., see Cighetti, G., 67 Godsey. F., see Renaud, S.. 37 Goto, Y.. see Homma. Y.. 23 Grab, B.. see James, R.W., 49 Hamsten, A., L. Iselius, G. DahlCn and U. de Faire (Genetic and cultural inheritance of serum lipids. low and high density hpoprotein cholesterol and serum apolipoproteins A-I, A-II and B). 199 Hill, T.. see Kohlmeier, M.. 29 Publishers
Ireland,
Ltd
296
Hoeg, J.M., M.B. Maher, K.R. Bailey and H.B. Brewer. Jr. (The effects of mevinolin and neomycin alone and in combination on plasma lipid and lipoprotein concentrations in type II hyperlipoproteinemia), 209 Homma, Y., Y. Mikami, H. Tamachi. N. Nakaya, H. Nakamura, G. Araki and Y. Goto (Comparison of selectivity of LDL removal by double filtration and dextran-sulfate cellulose column plasmapheresis), 23 Howard, Jr., C.F., see Beatty, C.H., 111 Hutchins, G.M., see Friedman, M.H., 161 Isabelle, L.M., see Malinow, M.R.. 15 Iselius, L., see Hamsten, A., 199 Ishibashi, S., see Murase, T., 1 James, R.W., B. Martin, D. Pometta, B. Grab and A. Suenram (Apoprotein D in a healthy, male population and in male myocardial infarction patients and their male, first-degree relatives), 49 Jiao. S.. K. Kameda, Y. Matsuzawa, M. Kubo, K. Nonaka and S. Tarui (Influence of endogenous hyperinsulinism on high density lipoprotein, level in type 2 (non-insulin-dependent ) diabetes mellitus and impaired glucose tolerance), 279 Kameda, K., see Jiao, S., 279 Khashinov, Kh.A., see Orekhov, A.N., 101 Kohlmeier, M., T. Hill, P. Remer and G. Schlierf (Influence of bezafibrate on plasma lipoproteins, biliary lipids and fecal sterols in healthy men), 29 Konarska, R., M. Shaikh, A. La Ville and P. Turner (Immunoglobulins containing circulating immune complexes in hypercholesterolaemic patients) (Letter to the Editors), 89 Kotake, C., see Murata, K., 251 Kritchevsky, D., see Sparks, J.D., 183 Kubo, M., see Jiao, S., 279 Kudryashov, S.A., see Orekhov, A.N., 101 Lapolla, A., P. Tessari, E. Duner, R. Trevisan, V. Zordan, R. Nosadini and A. Tiengo (Hormonal and metabolic profiles in patients with alcohol-induced, mixed hypertriglyceridemia before and after abstinence from ethanol and before and after a lipid-lowering diet), 151 LaPorte, R.E., see Deutscher, S., 221 La Ville, A., see Konarska, R., 89 Leo, T.A., see McIvor, M.E., 7 Lin, D., see Malinow, M.E., 15 Lynch, W.J., see Masarei, J.R.L., 79 McIvor, M.E., C.C. Cummings, M.A. Van Duyn, T.A. Leo, S. Margolis, K.M. Behall, J.E.
Michnowsky and A.I. Mendeloff (Long-term effects of guar gum on blood lipids), 7 McLaughlin. P., see Malinow, M.R., 15 Magni, F., see Eynard, A.R., 61 Maher, M.B., see Hoeg, J.M., 209 Malinow, M.R., P. McLaughlin, R. Aigner-Held, B. Upson, L.M. Isabelle, W.E. Connor and D. Lin (Absorption of cholesterol and /3sitosterol from cigarette smoke in Macacn mulatta), 15 Margolis, S., see McIvor. M.E., 7 Mark, F.F., see Friedman, M.H.. 161 Martin, B.. see James, R.W., 49 Martin, J.C., see Miller, G.J., 269 Martin, J.L., see Renaud, S., 37 Masarei, J.R.L., I.B. Puddey, I.L. Rouse, W.J. Lynch, R. Vandongen and L.J. Beilin (Effects of alcohol consumption on serum lipoprotein-lipid and apolipoprotein concentrations - Results from an intervention study in healthy subjects), 79 Mastacchi, R., see Radhakrishnamurthy, B., 141 Matsuzawa, Y., see Jiao, S., 279 Meade, T.W., see Miller, G.J., 269 Mendeloff, A.I.. see McIvor, M.E., 7 Mendy, F.. see Renaud, S., 37 Mest, H.-J., see Beitz, J., 95 Michnowsky, J.E., see McIvor, M.E., 7 Mikami, Y.. see Homma, Y., 23 Miller, G.J., J.C. Martin, J. Webster, H. Wilkes, N.E. Miller, W.H. Wilkinson and T.W. Meade (Association between dietary fat intake and plasma factor VII coagulant activity - A predictor of cardiovascular mortality), 269 Miller, N.E., see Miller, G.J., 269 Mitchinson. M.J., see Ball, H.Y., 173 Morazain, R., see Renaud, S., 37 Mori, N., see Murase, T., 1 Mori, W., see Murase, T.. 1 Motoyama. T., see Murata K., 251 Muller, G., see Beitz, J., 95 Murase, T., T. Oka, N. Yamada, N. Mori, S. Ishibashi, F. Takaku and W. Mori (Immunohistochemical localization of apolipoprotein E in atherosclerotic lesions of the aorta and coronary arteries), 1 Murata, K., T. Motoyama and C. Kotake (Collagen types in various layers of the human aorta and their changes with the atherosclerotic process), 251 Musumeci, V., S. Rosa, A. Caruso, C. Zuppi, B. Zappacosta and F. Tutinelli (Abnormal diurnal changes in in-vivo platelet activation in patients with atherosclerotic diseases), 231
Nakamura. H., see Homma, Y., 23 Nakaya, N., see Homma, Y., 23 Nanji, A.A. and S.W. French (Alcoholic
bever-
291
ages and coronary heart disease) the Editors), 197 Nonaka. K., see Jiao, S., 279 Nosadini, R.. see Lapolla, A.. 151
(Letter
to
Oka. T., see Murase. T., 1 Orekhov. A.N., V.V. Tertov. S.A. Kudryashov, Kh.A. Khashimov and V.N. Smirnov (Primary culture of human aortic intima cells as a model for testing anti-atherosclerotic drugs Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipidlowering agents), 101 Paroni, R.. see Cighetti, G., 67 Pometta, D.. see James, R.W., 49 Puddey, LB., see Masarei, J.R.L., 79 Puntereri, A.. see Deutscher, S., 221 Radhakrishnamurthy. B., C. Sharma. R.R. Bhandaru, G.S. Berenson, L. Stanzani and R. Mastacchi (Studies of chemical and biological properties of a fraction of sulodexide, a heparin-like glycosaminoglycan). 141 Remer, P., see Kohlmeier, M., 29 Renaud, S.. R. Morazain, F. Godsey, E. Dumont, C. Thevenon, J.L. Martin and F. Mendy (Nutrients, platelet function and composition in nine groups of French and British farmers). 37 Robertson. Jr., A.L.. see Stastny, J.. 131 Robrecht. J., see Delanghe, J., 215 Rosa. S., see Musumeci, V.. 231 Rouse, I.L.. see Masarei, J.R.L.. 79 Russell, J.C. and R.M. Amy (Early atherosclerotic lesions in a susceptible rat model - The LA/N-corpulent rat). 119 Schlierf. G., see Kohlmeier. M., 29 Shaikh, M., see Konarska. R., 89 Sharma. C., see Radhakrishnamurthy. B., 141 Simons, L.A., see Balasubramaniam, S., 263 Sirtori, C.R., see Eynard, A.R., 61 Smirnov, V.N., see Orekhov, A.N., 101 Sparks, C.E., see Sparks, J.D., 183 Sparks, J.D., C.E. Sparks and D. Kritchevsky
(Hypercholesterolemia and aortic glycosaminoglycans of rabbits fed semi-purified diets containing sucrose and lactose), 183 Stanzani, L., see Radhakrishnamurthy, B., 141 Stastny, J.. E. Fosslien and A.L. Robertson. Jr. (Human aortic intima protein composition during initial stages of atherogenesis). 131 Stehbens, Suenram,
W.E., see Davis, P.F.. 55 A., see James. R.W., 49
Takaku, F., see Murase, T.. 1 Tamachi, H., see Homma. Y.. 23 Tarui, S.. see Jiao, S., 279 Taylor, F.H.. see Deutscher, S.. 221 Tertov, V.V., see Orekhov, A.N., 101 Tessari, P., see Lapolla, A., 151 Thevenon, C., see Renaud, S., 37 Tiengo, A., see Lapolla, A.. 151 Tremoli, E.. see Eynard, A.R., 61 Trevisan, R.. see Lapolla, A., 151 Turner, P.. see Konarska, R.. 89 Tutinelli, F., see Musumeci, V.. 231 Upson.
B., see Malinow,
M.R., 15
Van der Meer, R.. see Beynen, A.C.. 291 Vandongen. R., see Masarei, J.R.L., 79 Van Duyn, M.A., see M&or, M.E., 7 Van Gaal, L.F. and I.H. De Leeuw (Effects of smoking on lipid parameters during therapeutic weight loss) (Preliminary Note), 287 Velican, C. and D. Velican (Atherosclerotic involvement of coronary branch vessels), 237 Velican, D., see Velican. C., 237 Webster, J., see Miller, G.J.. 269 West. C.E.. see Beynen. A.C., 291 Wilkes, H., see Miller, G.J., 269 Wilkinson, W.H., see Miller, G.J., 269 Winkler, L., see Beitz, J., 95 Yamada.
N., see Murase,
T., 1
Zappacosta, B.. see Musumeci, V.. 231 Zordan, V., see Lapolla. A., 151 Zuppi, C., see Musumeci. V., 231